203 related articles for article (PubMed ID: 33412494)
1. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation.
Hsu WC; Ramesh S; Shibu MA; Chen MC; Wang TF; Day CH; Chen RJ; Padma VV; Li CC; Tseng YC; Huang CY
Phytomedicine; 2021 Feb; 82():153442. PubMed ID: 33412494
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.
Liao PH; Hsu HH; Chen TS; Chen MC; Day CH; Tu CC; Lin YM; Tsai FJ; Kuo WW; Huang CY
Oncogene; 2017 Apr; 36(14):1978-1990. PubMed ID: 27748761
[TBL] [Abstract][Full Text] [Related]
3. Hsa-miR-107 regulates chemosensitivity and inhibits tumor growth in hepatocellular carcinoma cells.
Chen HA; Li CC; Lin YJ; Wang TF; Chen MC; Su YH; Yeh YL; Padma VV; Liao PH; Huang CY
Aging (Albany NY); 2021 Apr; 13(8):12046-12057. PubMed ID: 33901009
[TBL] [Abstract][Full Text] [Related]
4. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ
Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma.
Hu XY; Liang JY; Guo XJ; Liu L; Guo YB
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
[TBL] [Abstract][Full Text] [Related]
7. Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells.
Li T; Xu WS; Wu GS; Chen XP; Wang YT; Lu JJ
Asian Pac J Cancer Prev; 2014; 15(4):1745-9. PubMed ID: 24641402
[TBL] [Abstract][Full Text] [Related]
8. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
9. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
Liang RR; Zhang S; Qi JA; Wang ZD; Li J; Liu PJ; Huang C; Le XF; Yang J; Li ZF
Int J Oncol; 2012 Sep; 41(3):969-78. PubMed ID: 22684543
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
[TBL] [Abstract][Full Text] [Related]
11. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy.
Schuchmann M; Schulze-Bergkamen H; Fleischer B; Schattenberg JM; Siebler J; Weinmann A; Teufel A; Wörns M; Fischer T; Strand S; Lohse AW; Galle PR
Oncol Rep; 2006 Jan; 15(1):227-30. PubMed ID: 16328060
[TBL] [Abstract][Full Text] [Related]
13. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
[TBL] [Abstract][Full Text] [Related]
14. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis.
Li W; Tian YH; Liu Y; Wang Z; Tang S; Zhang J; Wang YP
J Toxicol Sci; 2016; 41(3):417-28. PubMed ID: 27193733
[TBL] [Abstract][Full Text] [Related]
15. Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.
Hsu HH; Cheng LH; Ho TJ; Kuo WW; Lin YM; Chen MC; Lee NH; Tsai FJ; Tsai KH; Huang CY
Tumour Biol; 2014 Jan; 35(1):303-13. PubMed ID: 23990456
[TBL] [Abstract][Full Text] [Related]
16. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
Hou H; Ge C; Sun H; Li H; Li J; Tian H
Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
[TBL] [Abstract][Full Text] [Related]
17. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro.
Qu L; Zhang H; Yang Y; Yang G; Xin H; Ling C
Pharm Biol; 2016 Aug; 54(8):1445-57. PubMed ID: 26810384
[TBL] [Abstract][Full Text] [Related]
18. 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells.
Fu M; Wan F; Li Z; Zhang F
Biochem Biophys Res Commun; 2016 Mar; 471(2):267-73. PubMed ID: 26773495
[TBL] [Abstract][Full Text] [Related]
19. Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway.
Liu YM; Cong S; Cheng Z; Hu YX; Lei Y; Zhu LL; Zhao XK; Mu M; Zhang BF; Fan LD; Yu L; Cheng ML
Eur J Pharmacol; 2020 Jun; 876():172946. PubMed ID: 31996320
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.
Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M
Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
